Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
SEED BRACHYTHERAPY CESIUM -131 THERAPY D GAMMATILE GT-08 (CDM SUP-GT-08) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 30, 2026 , from http://ppman.hank.ai/transparency/procedure/SUP-GT-08/by-state?code_type=CDM
“SEED BRACHYTHERAPY CESIUM -131 THERAPY D GAMMATILE GT-08 (CDM SUP-GT-08) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/SUP-GT-08/by-state?code_type=CDM. Accessed
October 30, 2026 .
“SEED BRACHYTHERAPY CESIUM -131 THERAPY D GAMMATILE GT-08 (CDM SUP-GT-08) by State,” HANK Price Transparency ,
accessed October 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/SUP-GT-08/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
SUP-GT-08 — Seed Brachytherapy Cesium -131 Therapy D Gammatile Gt-08
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$14,700
National median
$8,169 – $51,275
IQR (p25 – p75)
8
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$5,682
vs. negotiated
-61.3%
Hospitals reporting
8
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for SUP-GT-08 (CDM), with interquartile range
State Median p25 p75
IN $71,521 $51,275 $77,023
KS $12,722 $6,478 $14,700
AL $7,576 $7,305 $9,469
MA $6,174 $5,413 $9,469